1. Home
  2. SKYT vs ORIC Comparison

SKYT vs ORIC Comparison

Compare SKYT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWater Technology Inc.

SKYT

SkyWater Technology Inc.

HOLD

Current Price

$28.08

Market Cap

850.8M

Sector

Technology

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$8.68

Market Cap

783.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYT
ORIC
Founded
1991
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
850.8M
783.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
SKYT
ORIC
Price
$28.08
$8.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
13
Target Price
$19.40
$19.73
AVG Volume (30 Days)
1.8M
1.4M
Earning Date
02-25-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.62
N/A
Revenue
$346,587,000.00
N/A
Revenue This Year
$28.48
N/A
Revenue Next Year
$41.29
N/A
P/E Ratio
$10.81
N/A
Revenue Growth
0.19
N/A
52 Week Low
$5.67
$3.90
52 Week High
$28.73
$14.93

Technical Indicators

Market Signals
Indicator
SKYT
ORIC
Relative Strength Index (RSI) 76.16 37.36
Support Level $18.15 $7.84
Resistance Level $20.25 $8.33
Average True Range (ATR) 1.82 0.44
MACD 1.17 0.11
Stochastic Oscillator 91.69 48.39

Price Performance

Historical Comparison
SKYT
ORIC

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: